General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.7M |
18 |
15/04/25 |
15/04/25 |
General
|
12K
|
4.7M
|
18
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.7M |
21 |
15/04/25 |
15/04/25 |
General
|
12K
|
4.7M
|
21
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.7M |
12 |
15/04/25 |
15/04/25 |
General
|
12K
|
4.7M
|
12
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.7M |
61 |
15/04/25 |
15/04/25 |
General
|
12K
|
4.7M
|
61
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.7M |
22 |
15/04/25 |
15/04/25 |
General
|
12K
|
4.7M
|
22
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.7M |
33 |
15/04/25 |
15/04/25 |
General
|
12K
|
4.7M
|
33
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Change of Director's Interest Notice - DT
|
|
Davisite
|
9 |
3.2K |
10 |
11/04/25 |
11/04/25 |
ASX - By Stock
|
9
|
3.2K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 Phase 1 Trial Opens for Patient Enrolment
|
|
Davisite
|
158 |
41K |
7 |
09/04/25 |
09/04/25 |
ASX - By Stock
|
158
|
41K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 Phase 1 Trial Opens for Patient Enrolment
|
|
Davisite
|
158 |
41K |
16 |
09/04/25 |
09/04/25 |
ASX - By Stock
|
158
|
41K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 Phase 1 Trial Opens for Patient Enrolment
|
|
Davisite
|
158 |
41K |
34 |
09/04/25 |
09/04/25 |
ASX - By Stock
|
158
|
41K
|
34
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 Phase 1 Trial Opens for Patient Enrolment
|
|
Davisite
|
158 |
41K |
23 |
09/04/25 |
09/04/25 |
ASX - By Stock
|
158
|
41K
|
23
|
|
ASX - By Stock
|
CU6 |
Re:
Broker Consensus
|
|
Davisite
|
21 |
9.9K |
17 |
09/04/25 |
09/04/25 |
ASX - By Stock
|
21
|
9.9K
|
17
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.7M |
42 |
08/04/25 |
08/04/25 |
General
|
12K
|
4.7M
|
42
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.7M |
13 |
08/04/25 |
08/04/25 |
General
|
12K
|
4.7M
|
13
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.7M |
11 |
08/04/25 |
08/04/25 |
General
|
12K
|
4.7M
|
11
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.7M |
7 |
07/04/25 |
07/04/25 |
General
|
12K
|
4.7M
|
7
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.7M |
3 |
07/04/25 |
07/04/25 |
General
|
12K
|
4.7M
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.7M |
43 |
07/04/25 |
07/04/25 |
General
|
12K
|
4.7M
|
43
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.7M |
24 |
07/04/25 |
07/04/25 |
General
|
12K
|
4.7M
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 Phase 1 Trial Opens for Patient Enrolment
|
|
Davisite
|
158 |
41K |
30 |
07/04/25 |
07/04/25 |
ASX - By Stock
|
158
|
41K
|
30
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.7M |
20 |
06/04/25 |
06/04/25 |
General
|
12K
|
4.7M
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 Phase 1 Trial Opens for Patient Enrolment
|
|
Davisite
|
158 |
41K |
40 |
06/04/25 |
06/04/25 |
ASX - By Stock
|
158
|
41K
|
40
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 Phase 1 Trial Opens for Patient Enrolment
|
|
Davisite
|
158 |
41K |
15 |
06/04/25 |
06/04/25 |
ASX - By Stock
|
158
|
41K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 Phase 1 Trial Opens for Patient Enrolment
|
|
Davisite
|
158 |
41K |
20 |
05/04/25 |
05/04/25 |
ASX - By Stock
|
158
|
41K
|
20
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Announces Decision to Discontinue Wet AMD Trials
|
|
Davisite
|
137 |
62K |
5 |
02/04/25 |
02/04/25 |
ASX - By Stock
|
137
|
62K
|
5
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Announces Decision to Discontinue Wet AMD Trials
|
|
Davisite
|
137 |
62K |
4 |
02/04/25 |
02/04/25 |
ASX - By Stock
|
137
|
62K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Ethics approval for RC220 Trial at Gosford Wyong Hospitals
|
|
Davisite
|
62 |
19K |
65 |
01/04/25 |
01/04/25 |
ASX - By Stock
|
62
|
19K
|
65
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Ethics approval for RC220 Trial at Gosford Wyong Hospitals
|
|
Davisite
|
62 |
19K |
117 |
31/03/25 |
31/03/25 |
ASX - By Stock
|
62
|
19K
|
117
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Announces Decision to Discontinue Wet AMD Trials
|
|
Davisite
|
137 |
62K |
6 |
31/03/25 |
31/03/25 |
ASX - By Stock
|
137
|
62K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Announces Decision to Discontinue Wet AMD Trials
|
|
Davisite
|
137 |
62K |
11 |
31/03/25 |
31/03/25 |
ASX - By Stock
|
137
|
62K
|
11
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Announces Decision to Discontinue Wet AMD Trials
|
|
Davisite
|
137 |
62K |
10 |
31/03/25 |
31/03/25 |
ASX - By Stock
|
137
|
62K
|
10
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Announces Decision to Discontinue Wet AMD Trials
|
|
Davisite
|
137 |
62K |
12 |
31/03/25 |
31/03/25 |
ASX - By Stock
|
137
|
62K
|
12
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Announces Decision to Discontinue Wet AMD Trials
|
|
Davisite
|
137 |
62K |
0 |
31/03/25 |
31/03/25 |
ASX - By Stock
|
137
|
62K
|
0
|
|
ASX - By Stock
|
BC8 |
Re:
Ann: Response to ASX Price Query
|
|
Davisite
|
16 |
6.8K |
20 |
28/03/25 |
28/03/25 |
ASX - By Stock
|
16
|
6.8K
|
20
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Voluntary suspension
|
|
Davisite
|
708 |
220K |
3 |
28/03/25 |
28/03/25 |
ASX - By Stock
|
708
|
220K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Voluntary suspension
|
|
Davisite
|
708 |
220K |
1 |
28/03/25 |
28/03/25 |
ASX - By Stock
|
708
|
220K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Voluntary suspension
|
|
Davisite
|
708 |
220K |
3 |
27/03/25 |
27/03/25 |
ASX - By Stock
|
708
|
220K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Race Temp Check Survey
|
|
Davisite
|
37 |
7.5K |
12 |
27/03/25 |
27/03/25 |
ASX - By Stock
|
37
|
7.5K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Ethics approval received for RC220 Phase 1 Trial
|
|
Davisite
|
93 |
28K |
26 |
27/03/25 |
27/03/25 |
ASX - By Stock
|
93
|
28K
|
26
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Initiates First AU Site for Phase 1 Solid Tumour Trial
|
|
Davisite
|
96 |
23K |
27 |
27/03/25 |
27/03/25 |
ASX - By Stock
|
96
|
23K
|
27
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Initiates First AU Site for Phase 1 Solid Tumour Trial
|
|
Davisite
|
96 |
23K |
63 |
27/03/25 |
27/03/25 |
ASX - By Stock
|
96
|
23K
|
63
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Voluntary suspension
|
|
Davisite
|
708 |
220K |
11 |
27/03/25 |
27/03/25 |
ASX - By Stock
|
708
|
220K
|
11
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Voluntary suspension
|
|
Davisite
|
708 |
220K |
3 |
27/03/25 |
27/03/25 |
ASX - By Stock
|
708
|
220K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Voluntary suspension
|
|
Davisite
|
708 |
220K |
14 |
19/03/25 |
19/03/25 |
ASX - By Stock
|
708
|
220K
|
14
|
|
ASX - By Stock
|
SPR |
Re:
Cruch time....
|
|
Davisite
|
324 |
103K |
5 |
16/03/25 |
16/03/25 |
ASX - By Stock
|
324
|
103K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Response to ASX Query Letter
|
|
Davisite
|
145 |
32K |
5 |
16/03/25 |
16/03/25 |
ASX - By Stock
|
145
|
32K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Response to ASX Query Letter
|
|
Davisite
|
145 |
32K |
4 |
16/03/25 |
16/03/25 |
ASX - By Stock
|
145
|
32K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Response to ASX Query Letter
|
|
Davisite
|
145 |
32K |
5 |
15/03/25 |
15/03/25 |
ASX - By Stock
|
145
|
32K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Update - Proposed issue of securities - BIT
|
|
Davisite
|
19 |
4.1K |
9 |
10/03/25 |
10/03/25 |
ASX - By Stock
|
19
|
4.1K
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
Broker Consensus
|
|
Davisite
|
21 |
9.9K |
14 |
09/03/25 |
09/03/25 |
ASX - By Stock
|
21
|
9.9K
|
14
|
|